Screener
Moderna MRNA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Moderna’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001682852-26-000060
FAQ
- What is Moderna's restricted cash?
- Moderna (MRNA) reported restricted cash of $0 in Q1 2026.
- How has Moderna's restricted cash changed year-over-year?
- Moderna's restricted cash decreased by 100.0% year-over-year, from $1M to $0.
- What is the long-term trend for Moderna's restricted cash?
- Over 2 years (2020 to 2022), Moderna's restricted cash has grown at a 241.0% compound annual growth rate (CAGR), from $1.03M to $12M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Moderna's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude